HELIX BIOTECH
LIVE

Serial Number

97792209

Owner

Helix Biotech, Inc

Attorney

Wade R. Orr

Filing Date

Feb 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HELIX BIOTECH Trademark

Serial Number: 97792209

HELIX BIOTECH is a trademark filed by Helix Biotech, Inc on February 13, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Helix Biotech, Inc (5 trademarks)

7141 Regal Lane
Knoxville, TN 37918

Entity Type: 03

Trademark Details

Filing Date

February 13, 2023

Registration Date

Not Registered

Goods & Services

Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Basic and clinical research in the field of respiratory science and medicine; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Medical and scientific research, namely, conducting clinical trials for others; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Testing, analysis and evaluation of leaf and petiole samples; Working on and evaluation of chemical analyses

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 23, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 20, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 19, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 18, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 15, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 15, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 15, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 8, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 8, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 8, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 10, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 3, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2023 NWOS
NEW APPLICATION ENTERED
Feb 16, 2023 NWAP